BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2014
View Archived Issues
Pearl Therapeutics presents first clinical data for PT-010
Read More
CytRx begins phase Ib trial of aldoxorubicin and ifosfamide or mesna
Read More
biOasis advances lysosomal storage disease program
Read More
Roche characterizes novel alpha7-nAChR PAM
Read More
Collaboration leads to state-dependent Na(v)1.7 inhibitors for the treatment of pain
Read More
rAvPAL-loaded erythrocytes as enzyme replacement therapy for phenylketonuria
Read More
Cellceutix updates on i.v. brilacidin trial and submits IND for oral rinse formulation
Read More
Aurigene Discovery Technologies divulges novel BTK inhibitors
Read More
GlaxoSmithKline discloses novel RIP-1 inhibitors
Read More
Allergan presents new S1P1 receptor modulators
Read More
Merck & Co. synthesizes new Kir1.1 channel blockers
Read More
Kala Pharmaceuticals patents novel VEGFR-2 inhibitors
Read More
Meiji Seika presents a novel antifungal with improved efficacy against dermatophytes
Read More
CURx Pharmaceuticals licenses Captisol-formulated lamotrigine from Ligand Pharmaceuticals
Read More
Eli Lilly and Boehringer Ingelheim's insulin glargine biosimilar approved in E.U.
Read More
Mimetogen releases topline data from phase III dry eye study of MIM-D3
Read More
Serodus reports phase IIa data on SER-100 in patients with systolic hypertension
Read More
NIAAA to study gabapentin enacarbil for the treatment of alcohol use disorder
Read More
Transparency Life Sciences receives grant to support phase IIa trial of lisinopril in MS
Read More
First clinical results for 2B3-201 as potential new treatment for acute relapses in MS
Read More
Senesco Technologies changes name to Sevion Therapeutics
Read More
MabVax Therapeutics receives stockholder approval for name change
Read More
Dovobet ointment launched in Japan
Read More
SRI International and Nobelpharma sign licensing agreement on SR-16234 for endometriosis
Read More
FDA approves Contrave for chronic weight management
Read More
Baxter International to name biopharmaceutical entity Baxalta
Read More
FDA advisory committee recommends approval of liraglutide for obesity
Read More
Rhodiola rosea extract proves beneficial for stress-induced sexual dysfunction in rodents
Read More